InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.920 0.04 (1.39%)+

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$545 Notice under section 249D 18 Jun 2015 1:51PM $0.035 $2.920 risen by 8,242.86%
$545 Final Director's Interest Notice 11 Jun 2015 8:26AM $0.036 $2.920 risen by 8,011.11%
$545 Final Director's Interest Notice 11 Jun 2015 8:26AM $0.036 $2.920 risen by 8,011.11%
$545 Alchemia Provides Investor Update 10 Jun 2015 8:41AM $0.040 $2.920 risen by 7,200%
$545 ACL announces retirement of directors 10 Jun 2015 8:26AM $0.040 $2.920 risen by 7,200%
$545 Ceasing to be a substantial holder from AEF 2 Jun 2015 3:32PM $0.042 $2.920 risen by 6,852.38%
$545 Change in substantial holding from SNC 1 Jun 2015 2:57PM $0.042 $2.920 risen by 6,852.38%
$545 Reinstatement to Official Quotation 29 May 2015 9:07AM $0.083 $2.920 risen by 3,418.07%
$545 Fondaparinux Quarterly Profit Share 29 May 2015 9:07AM $0.083 $2.920 risen by 3,418.07%
$545 Suspension from Official Quotation 26 May 2015 10:17AM $0.083 $2.920 risen by 3,418.07%
$545 Response to ASX Price Query 22 May 2015 10:08AM $0.083 $2.920 risen by 3,418.07%
$545 Request for Trading Halt 22 May 2015 10:05AM $0.083 $2.920 risen by 3,418.07%
$545 Trading Halt 22 May 2015 9:40AM $0.083 $2.920 risen by 3,418.07%
$545 Change in substantial holding 21 May 2015 10:00AM $0.066 $2.920 risen by 4,324.24%
$545 Ceasing to be a substantial holder from HHL 20 May 2015 5:11PM $0.065 $2.920 risen by 4,392.31%
$545 Becoming a substantial holder from AEF 20 May 2015 1:45PM $0.064 $2.920 risen by 4,462.50%
$545 Becoming a substantial holder 20 May 2015 8:25AM $0.062 $2.920 risen by 4,609.68%
$545 Appendix 4C - quarterly 30 Apr 2015 4:05PM $0.058 $2.920 risen by 4,934.48%
$545 S&P DJ Indices Announces March Quarterly Review 6 Mar 2015 8:44AM $0.061 $2.920 risen by 4,686.89%
$545 S&P DJ Indices Announces March Quarterly Review 6 Mar 2015 8:44AM $0.061 $2.920 risen by 4,686.89%
$545 Half Yearly Report and Accounts 26 Feb 2015 9:43AM $0.062 $2.920 risen by 4,609.68%
$545 Fondaparinux Quarterly Profit Share 19 Feb 2015 9:16AM $0.066 $2.920 risen by 4,324.24%
$545 Alchemia Investor Update - Strategic Review 29 Jan 2015 9:35AM $0.090 $2.920 risen by 3,144.44%
$545 Appendix 4C - quarterly 28 Jan 2015 1:48PM n/a $2.920 n/a
$545 ACL Receives $6.5m Refund from R&D Tax Incentive Program 31 Dec 2014 2:13PM $0.089 $2.920 risen by 3,180.90%

801 - 825 of 1019 results

Page 33 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.